Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C

Published:2021-10 Issue:3 Volume:67 Page:
ISSN:2724-5985
Container-title:Minerva Gastroenterology
language:
Short-container-title:Minerva Gastroenterol

Author:

FABRIZI Fabrizio,CERUTTI Roberta,ALFIERI Carlo M.,RIDRUEJO Ezequiel

Publisher

Edizioni Minerva Medica

Subject

General Engineering

Link

https://www.minervamedica.it/pdf.php?cod=R08Y2021N03A0244

Reference40 articles.

1. Global hepatitis report, 2017. Executive summary. World Health Organization; 2017 [Internet]. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report 2017-executive-summary/en/ [cited 2021, Jun 03].

2. Hepatitis C virus as a systemic disease: reaching beyond the liver

3. Extrahepatic manifestations of chronic hepatitis C virus infection

4. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population

5. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy;Diagnostics;2023-01-27

2. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?;Biomedicines;2022-02-24

3. Long-term benefits of viral clearance on extrahepatic manifestations of hepatitis C virus infection: the light at the end of the tunnel?;Minerva Gastroenterology;2021-10